Hepion Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00

Hepion Pharmaceuticals, Inc.

Notice received Sept. 3, 2024; bid price below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until March 3, 2025, to regain compliance.
To regain compliance, closing bid must be ≥$1.00 for at least 10 consecutive business days.
If not compliant, may qualify for a second 180-day period; otherwise Nasdaq will delist.
Common stock continues trading on Nasdaq under symbol HEPA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.